Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry of patients with Tetralogy of Fallot using implantable defibrillators

Official title: French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

Run by Paris Sudden Death Expertise Center · NCT03837574 · Data updated 2026-11-12

This study is creating a national registry to track adult patients in France with Tetralogy of Fallot who have implantable defibrillators, to better understand their health over time.

More Congenital Heart Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorParis Sudden Death Expertise Center
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedDecember 1, 2010
Main results expectedAugust 1, 2019
Study endsDecember 31, 2030
Registry record updatedFebruary 12, 2019
Trial IDNCT03837574 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old diagnosed with Tetralogy of Fallot who have received an implantable cardioverter defibrillator.

Probably not a fit

Patients under 18 years of age will not benefit from this study as they do not meet the inclusion criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a national registry of adult patients in France who have Tetralogy of Fallot and are using implantable cardioverter defibrillators (ICDs). It includes both retrospective data collection for cases prior to 2010 and prospective follow-up for cases after 2010, with annual updates. The study involves collaboration with all French centers that perform ICD implantation to ensure comprehensive data collection and central adjudication of events, including baseline ECG and endocavitary electrogram reviews.

Why it matters

Potential benefit: If successful, this registry could enhance understanding of outcomes and improve management strategies for patients with Tetralogy of Fallot and ICDs.

How similar studies have gone: While similar registries have been established for other congenital heart diseases, this specific registry for Tetralogy of Fallot and ICDs is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* tetralogy of Fallot
* implantable cardioverter defibrillator

Exclusion Criteria:

* age \< 18 years

Where it's running

  • Paris Sudden Death Expertise Center
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.